CD133, also known as prominin-1, is a trans-membrane glycoprotein expressed in various malignancies, such as breast carcinomas, brain tumors, pancreatic cancer, non-small cell lung cancer, hepatocellular carcinoma, and ovarian cancer. Here, PROM1 is linked to ovarian cancer.